Back to all stocks

SYF

9/9 Score

Synchrony Financial

Analysis Date: February 17, 2026

Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. In addition, it provides debt cancellation products to its credit card customers through online, mobile, and direct mail; healthcare payments and financing solutions under the CareCredit, Pets Best, and Walgreens brands; payments and financing solutions in the apparel, specialty retail, outdoor, music, and luxury industries; and point-of-sale consumer financing for audiology products and dental services. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. It serves digital, health and wellness, retail, home, auto, powersports, jewelry, pets, and other industries. Synchrony Financial was founded in 1932 and is headquartered in Stamford, Connecticut.

Buffettology Criteria

All 9 of 9 criteria passed

  • High ROE

    Return on Equity > 12%

    Value: 21.1%

  • High ROIC

    Return on Invested Capital > 9%

    Value: 9.4%

  • Cash Machine

    FCF / Assets > 5%

    Value: 8.3%

  • Fair Valuation

    Earnings Yield > 3.5%

    Value: 13.9%

  • Share Buybacks

    Share Count is Dropping

    Value: -9.7%

  • Defensible Moat

    Gross Profit Margin > 40%

    Value: 51.0%

  • Simple Business

    Not in a speculative sector (e.g., Biotech)

    Value: Financial Services

  • Conservative Debt

    Debt to Equity < 1.5

    Value: 0.91x

  • Consistent Growth

    5-Year Growth is Positive

    Value: 322.1%

Analysis Summary

This SYF business certainly looks promising, with a strong ROE and what appears to be a durable moat protecting its earnings. The manageable debt and consistent, albeit modest, growth suggest a well-run operation. It's a business that could potentially compound value over the long haul, provided management continues to allocate capital wisely.

Want More Analysis?

Get detailed scores for thousands of stocks and discover your next investment with the Vetted app.

Download Vetted